Aeluma, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ALMU research report →
Range $25 – $25
Price Chart
About the company
Aeluma, Inc. engineers optoelectronic components primarily for integration into sensing and communication systems. The company fabricates these devices utilizing compound semiconductor materials applied to large-diameter silicon wafers, similar to those employed in the widespread manufacturing of microelectronics.
- CEO
- Jonathan Klamkin
- IPO
- 2022
- Employees
- 26
- HQ
- Goleta, CA, US
Get TickerSpark's AI analysis on ALMU
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $94.22M
- P/E
- -8.71
- Fwd P/E
- 16.23
- PEG
- 0.06
- P/S
- 28.67
- P/B
- 1.90
- EV/EBITDA
- -4.52
- Div Yield
- 0.00%
- Gross Margin
- 30.65%
- Op Margin
- -351.98%
- Net Margin
- -313.45%
- ROE
- -23.73%
- ROIC
- -22.64%
Latest fiscal year · YoY change
- Revenue
- $4.46M-4.4%
- Gross Profit
- $1.57M-43.5%
- Op Income
- $-10,186,000
- Net Income
- $-9,159,000-203.1%
- EPS
- $-0.52-126.1%
- OCF Growth
- -184.5%
- FCF Growth
- -198.9%
- 52W High
- $31.79
- 52W Low
- $4.70
- 50D MA
- $9.71
- 200D MA
- $15.89
- Beta
- -0.06
- RSI (14)
- 29
- Avg Volume
- 651.39K
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Aeluma posted a smaller revenue base in Q1 fiscal 2027 but emphasized growing AI datacom traction, continued commercialization progress, and capacity expansion to support future demand.· November 12, 2026
- Revenue was $568,000, down from $1.4 million a year ago, and came primarily from government R&D contracts.
- GAAP net loss widened to $3.8 million, or $0.19 per share, versus $1.5 million, or $0.09 per share, last year.
- Cash and cash equivalents were $53.9 million at quarter-end, and the balance sheet remained debt-free.
- Management said fiscal 2027 revenue will come from R&D contracts and commercial NRE, with larger ramps expected in 2028 and beyond.
- Aeluma highlighted demand around slow-and-wide AI datacom architectures and said its photodetectors and quantum dot lasers are aligned with that trend.
First-quarter fiscal 2027 revenue was $568,000, compared with $1.4 million in the first fiscal quarter of 2026, with revenue primarily from government R&D contracts. GAAP net loss was $3.8 million, or $0.19 per basic and diluted share, versus a net loss of $1.5 million, or $0.09 per share, a year ago. Adjusted EBITDA loss was $2.7 million, versus an adjusted EBITDA loss of $450,000 in Q1 fiscal 2026. Cash and cash equivalents were $53.9 million at quarter-end, down from $56 million at June 30, 2026, and the balance sheet remained debt-free. For guidance, management said fiscal 2027 incoming revenue is expected to come from R&D contracts and commercial NRE, while investments in people, systems, and supply chain initiatives are expected to continue through the year; no next-quarter revenue or EPS guidance was given.
Jonathan Klamkin framed the quarter around a strengthening AI datacom opportunity and said Aeluma is positioning its technology for both slow-and-wide and fast-and-narrow interconnect architectures. He emphasized that the company’s heterogeneous integration platform can leverage gallium arsenide and silicon fabs rather than indium phosphide fabs, and said the new AIXTRON tool is for capacity expansion and next-generation development, not required for commercialization. His tone was constructive and optimistic, with repeated references to significant market demand, ongoing customer discussions, and commercialization progress.
Christopher Stewart said revenue of $568,000 was mainly from government R&D contracts and reiterated that the company is prioritizing funded R&D programs aligned with commercial priorities. He highlighted a GAAP net loss of $3.8 million, adjusted EBITDA loss of $2.7 million, and a strong balance sheet with $53.9 million in cash and cash equivalents and no debt. He also said the year-over-year increase in losses reflected more headcount, product development, and operational capability spending to support customer programs and commercialization, while noting the CHIPS program letter of intent for up to $30 million is still subject to diligence and definitive agreements.
Analysts focused on the new MOCVD purchase, the customer mix, NRE structures, and whether slow-and-wide architectures are becoming a more meaningful part of Aeluma’s opportunity. Management said the new system is not needed for commercialization, only for capacity expansion and advanced development, and that current in-house capacity plus Sumitomo Chemical Advanced Technologies is sufficient for the foreseeable future. On customer discussions, management said engagements span hyperscalers, system integrators, Tier 1 suppliers, and other parts of the value chain, and that commercial arrangements could range from development funding to sample qualification, with customer-specific qualification taking 9 to 18 months.
The call showed management believes Aeluma is well positioned as AI datacom architectures shift toward slow-and-wide designs and as industry attention increases around microdetectors and microemitters. Management also said its existing and partner capacity is sufficient for near-term commercialization, while the new tool and customer discussions could support larger ramps in 2028 and beyond.
Near-term reported financials remain small, with revenue of $568,000 and a wider net loss and EBITDA loss year over year. Management did not give near-term revenue guidance, said fiscal 2027 revenue should come only from R&D contracts and commercial NRE, and noted that customer-specific qualification can take 9 to 18 months, leaving execution and timing risk before any large commercial ramp.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 81.8%
- Shares Outstanding
- 19.35M
- Float Shares
- 15.83M
of shares held by institutions
107 13F filers
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Blackrock, Inc. | 1.10M | ▲ 126.04K |
| Vanguard Group Inc | 857.01K | ▲ 418.05K |
| D. E. Shaw & Co., Inc. | 797.98K | ▲ 772.98K |
| Vanguard Capital Management LLC | 599.12K | ▲ 24.70K |
| Millennium Management LLC | 529.00K | ▲ 130.71K |
| Geode Capital Management, LLC | 378.70K | ▲ 60.69K |
| State Street Corp | 255.29K | ▲ 1.12K |
| Marshall Wace, Llp | 199.69K | ▲ 103.73K |
| Morgan Stanley | 136.94K | ▲ 95.79K |
| Awm Investment Company, Inc. | 131.40K | 0 |
| Northern Trust Corp | 123.50K | ▲ 7.58K |
| Bank Of New York Mellon Corp | 119.02K | ▲ 26.32K |
Held by 114 ETFs
Biggest fund positions in ALMU by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Oct 12, 26 | Klamkin Jonathan | sell | 100,000 |
| Sep 30, 26 | Stewart Christopher P. | other | 5,697 |
| Sep 21, 26 | Stewart Christopher P. | other | 37,568 |
| Sep 21, 26 | Stewart Christopher P. | other | 4,042 |
| Sep 21, 26 | Stewart Christopher P. | other | 1,450 |
| Sep 21, 26 | Stewart Christopher P. | other | 15,886 |
| Sep 21, 26 | Klamkin Jonathan | sell | 100,000 |
| Sep 21, 26 | Klamkin Jonathan | other | 75,135 |
| Sep 21, 26 | Klamkin Jonathan | other | 12,675 |
| Sep 21, 26 | Klamkin Jonathan | other | 4,547 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our ALMU coverage
Recent articles, reports, and earnings notes.
No research on ALMU yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate ALMU report →Aeluma, Inc. (ALMU) Q1 2027 Earnings Call Transcript
seekingalpha.com · Nov 13
Aeluma Q1 Earnings Call Highlights
marketbeat.com · Nov 12
Aeluma Announces First Quarter Fiscal 2027 Financial Results
globenewswire.com · Nov 12
Aeluma Executes Agreement with AIXTRON for Purchase of G10-AsP MOCVD
globenewswire.com · Nov 12
Aeluma to Participate in 2026 Stifel Deep Tech Summit
globenewswire.com · Nov 5
Aeluma to Announce First Quarter Fiscal Year 2027 Financial Results on November 12, 2026
globenewswire.com · Oct 29
Aeluma to Participate in Upcoming Investor Conferences
globenewswire.com · Oct 27
Comparing Aeluma (NASDAQ:ALMU) & Photronics (NASDAQ:PLAB)
defenseworld.net · Oct 22
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.